The 3M Company (NYSE: MMM), traditionally known as Minnesota Mining and Manufacturing, operates at one of the most critical structural and strategic inflection points in its century-long corporate history. Functioning as a diversified global manufacturer and materials science conglomerate, the enterprise has spent the latter half of the early 2020s navigating a profound metamorphosis. This transformation was most visibly catalyzed by the April 2024 tax-free spin-off of its highly profitable Health Care segment into an independent public entity, Solventum Corporation.1 While this strategic divestiture surgically removed approximately 25% of 3M’s legacy revenue base, it simultaneously allowed the surviving corporate structure—the "New 3M"—to completely refocus its capital and operational bandwidth on its core competencies: industrial automation, pe ...